Ireland
--:--IST

← All drugs

Ventolin

Salbutamol

The classic blue reliever inhaler for asthma.

Generic name
Salbutamol
Brand name
Ventolin
Marketed by
GlaxoSmithKline
First FDA approval
1 May 1981

Where Salbutamol is approved

All regulators →

Of the three regulators tracked here, the first to approve Salbutamol was Canada, on 25 Jan 1994.

USUnited States (FDA)
No FDA approval of a single-substance product in Drugs@FDA
First original NDA/BLA approval
EUEuropean Union (EMA)
No centralised EU authorisation (it may be authorised nationally)
First centralised authorisation
CACanada (Health Canada)
25 Jan 1994
Pms-salbutamol
Notice of Compliance 5533
First new-drug NOC

From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.

What health systems spend on Salbutamol

All medicines →
ENNHS England
£49.6m
15,498,680 items dispensed, Aug 2025 to Jul 2026
-20% on the previous 12 months
Net ingredient cost, community prescriptions
USUS Medicaid
No single-ingredient product reimbursed by Medicaid in 2025
Amount Medicaid reimbursed, before rebates

From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.

How Salbutamol works

All drug targets →
  • Beta-2 adrenergic receptor agonist Agonist
    Target: ADRB2 adrenoceptor beta 2
    ✓ In ChEMBL and the Guide to Pharmacology
Diseases it has been tested for in clinical trials, by furthest phase
  • Abdominal painPhase 3
  • Riley-Day syndromePhase 3
  • WheezingPhase 3
  • Persistent fetal circulation syndromePhase 3
  • Pulmonary arterial hypertensionPhase 3
  • Pulmonary hypertensionPhase 3
  • Pulmonary hypertension, neonatalPhase 3
  • Congestive heart failurePhase 2/3
  • Myasthenia gravisPhase 2/3
  • Pulmonary edemaPhase 2/3
26 diseases in all

Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL714, CC BY-SA 3.0. Targets checked against the IUPHAR/BPS Guide to PHARMACOLOGY (2026.3), ligand 558, CC BY-SA 4.0. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.

Patient leaflets for Salbutamol

The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.

Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.

Reference identifiers for Salbutamol

ChEMBL
CHEMBL714
DrugBank
DB01001
PubChem CID
2083
CAS number
18559-94-9
FDA UNII
QF8SVZ843E
Wikidata
Q93346928

Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.

What Ventolin is used for

Salbutamol (Ventolin) is the classic blue reliever inhaler for asthma. It belongs to the Short-acting bronchodilator class.

Explore more

How this page is built

The facts on this page are pulled directly from official U.S. FDA datasets — they are not written from memory. Each field below names the dataset it came from, so you can check it yourself.

Plain-English summaries and drug-class explainers are written and reviewed by Sreepriya Prasannan (MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany). Data is retrieved automatically from the sources above and cross-checked with AI-assisted verification (Anthropic's Claude) — brand and generic names are matched against the exact FDA product record so that a combination product or a different formulation cannot be mistaken for the drug on this page. An editor reviews the result before publication. We describe this in full in our editorial standards and corrections policy. The FDA data on this page was last retrieved on 5 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.